Literature DB >> 10965893

Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations.

J W Morgan1, N Kouttab, D Ford, A L Maizel.   

Abstract

Isolation of distinct subpopulations of density-fractionated normal human B lymphocytes reveals that the requirements for up-regulation of the vitamin D receptor (VDR) and initiation of 1alpha,25-dihydroxyvitamin D3 [1alpha,25-(OH)2D3]-mediated genomic trans-activation are dependent upon the state of cellular activation. The kinetics of the response differ widely among these B cell subpopulations. However, these density-fractionated B cell subpopulations are phenotypically diverse and therefore are not representative of distinct stages of B cell maturation and differentiation. To examine the role of B cell differentiation on the induction and maintenance of biological receptivity to 1,25-(OH)2D3, we purified naive, germinal center, and memory B cells based on their expression of CD38 and CD44 surface antigens and surface Ig isotype. These phenotypically defined B cell subpopulations were all found to constitutively express VDR, and all exhibited similar activation requirements and kinetics for initiation of 1,25(OH)2D3-mediated genomic trans-activation. Taken together, these results suggest that defined stages of differentiation in normal B cells are not significant predicators of VDR expression or receptivity to 1,25-(OH)2D3. Rather, the degree of cellular activation, regardless of maturation stage, determines whether the effects of this immunoregulatory hormone will influence a mature B lymphocyte.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965893     DOI: 10.1210/endo.141.9.7666

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

2.  Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.

Authors:  Kojo S J Elenitoba-Johnson; Stephen D Jenson; Robert T Abbott; Robert A Palais; Sandra D Bohling; Zhaosheng Lin; Sheryl Tripp; Paul J Shami; Lai Y Wang; Robert W Coupland; Rena Buckstein; Bayardo Perez-Ordonez; Sherrie L Perkins; Ian D Dube; Megan S Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

3.  Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes.

Authors:  Surya Pavan Yenamandra; Ulf Hellman; Bettina Kempkes; Suhas Deoram Darekar; Sabine Petermann; Tom Sculley; George Klein; Elena Kashuba
Journal:  Cell Mol Life Sci       Date:  2010-07-01       Impact factor: 9.261

Review 4.  Vitamin D3: a helpful immuno-modulator.

Authors:  Michelino Di Rosa; Michele Malaguarnera; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

Review 5.  Pre- and Postnatal Vitamin D Status and Allergy Outcomes in Early Childhood.

Authors:  Kristina Rueter; Aris Siafarikas; Debra J Palmer; Susan L Prescott
Journal:  Biomedicines       Date:  2022-04-19

6.  P38 mitogen activated protein kinase expression and regulation by interleukin-4 in human B cell non-Hodgkin lymphomas.

Authors:  Hu Ding; Ali M Gabali; Stephen D Jenson; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Hematop       Date:  2009-10-21       Impact factor: 0.196

7.  1alpha,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization.

Authors:  Y Van Der Stede; T Verfaillie; E Cox; F Verdonck; B M Goddeeris
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

8.  Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma.

Authors:  Christoph Renné; Alexander H Benz; Martin L Hansmann
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

9.  Potential impact of B cells on T cell function in multiple sclerosis.

Authors:  Sara Ireland; Nancy Monson
Journal:  Mult Scler Int       Date:  2011-03-24

10.  Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study.

Authors:  Marco Atteritano; Stefania Sorbara; Gianluca Bagnato; Giovanni Miceli; Donatella Sangari; Salvatore Morgante; Elisa Visalli; Gianfilippo Bagnato
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.